Literature DB >> 6254399

Establishment of a canine cell line: derivation, characterization, and viral spectrum.

L N Binn, R H Marchwicki, E H Stephenson.   

Abstract

A cell line, designated A-72, for virus studies was established from a tumor surgically removed from a female, 8-year-old Golden Retriever dog. Following explant culture, the cells were serially passaged 135 times. The A-72 cells maintained a fibroblastic appearance and, at the 123rd passage, had a population doubling time of approximately 27 hours. Karyotypic analysis of the high passage cells showed the modal 2n chromosome number was 92 to 93. Using starch gel electrophoresis for enzyme characterization, the electrophoretic mobilities of enzymes extracted from A-72 cells were identical with those of canine peritoneal fibroblasts and primary canine kidney cells. The A-72 cells were susceptible to infection with infectious canine hepatitis virus, canine adenovirus type II, canine herpesvirus, canine parainfluenza virus, and canine coronavirus, but were not susceptible to canine distemper virus or the minute virus of canines. These cells have been particularly useful for studies of the fastidious canine coronaviruses, as the commonly used primary canine kidney cells exhibit varied susceptibility to these viruses.

Entities:  

Mesh:

Year:  1980        PMID: 6254399

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  24 in total

1.  Comparative immunological characterization of type-specific and conserved B-cell epitopes of pinniped, felid and canid herpesviruses.

Authors:  M Lebich; T C Harder; H R Frey; I K Visser; A D Osterhaus; B Liess
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

2.  The kinetics-based enzyme-linked immunosorbent assay for coronavirus antibodies in cats: calibration to the indirect immunofluorescence assay and computerized standardization of results through normalization to control values.

Authors:  J E Barlough; R H Jacobson; D R Downing; T J Lynch; F W Scott
Journal:  Can J Vet Res       Date:  1987-01       Impact factor: 1.310

3.  Latex agglutination test for detecting feline panleukopenia virus, canine parvovirus, and parvoviruses of fur animals.

Authors:  P M Veijalainen; E Neuvonen; A Niskanen; T Juokslahti
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

4.  Canine parvovirus host range is determined by the specific conformation of an additional region of the capsid.

Authors:  J S Parker; C R Parrish
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Cryopreserved erythrocytes in clinical laboratory hemagglutination and hemagglutination inhibition tests.

Authors:  R K Maes; M M Hayes; J P Newman
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

6.  Studies of enteric coronaviruses in a feline cell line.

Authors:  R D Woods
Journal:  Vet Microbiol       Date:  1982-11       Impact factor: 3.293

7.  Multiple amino acids in the capsid structure of canine parvovirus coordinately determine the canine host range and specific antigenic and hemagglutination properties.

Authors:  S F Chang; J Y Sgro; C R Parrish
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo.

Authors:  U Truyen; C R Parrish
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Coronavirus species specificity: murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein.

Authors:  S R Compton; C B Stephensen; S W Snyder; D G Weismiller; K V Holmes
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Antigenic relationships between canine parvovirus type 2, feline panleukopenia virus and mink enteritis virus using conventional antisera and monoclonal antibodies.

Authors:  C R Parrish; L E Carmichael; D F Antczak
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.